CD8A and neoplasm: Research teams in this area focus their main efforts on delivering plasmids encoding tumor antigens to DCs and tumor cells to determine if this approach could be useful, considering the adjuvant properties of BGs that could affect them positively and lead to an effective Ag-specific T CD8+ cell response [148].